Trial Site News
Generic selectors
Exact matches only
Search in title
Search in content
Search in posts
Search in pages
  • Register
  • Log In
  • News
  • Video
  • Podcast
  • More
Trial Site News
  • News For You
  • Op-Eds
  • Video
  • Podcasts
  • Investor Watch
  • Write for us
  • News for You
  • Op-Eds
  • Video
  • Podcasts
  • Covid-19
  • Investor Watch

Topic: Gene Therapy

Bluebird Halts Gene-based Therapy Trials as Patients Diagnosed with Cancer—Stock Plummets

Two patients with sickle cell disease involved with a gene-based therapy trial now have been diagnosed with cancer, and the […]

Bluebird Halts Gene-based Therapy Trials as Patients Diagnosed with Cancer—Stock Plummets
2 weeks ago
Share

UK’s NICE Rejects bluebird bio: Questions Value Price Tag & Nominal Clinical Evidence While Sponsor Shocked

A gene therapy for patients with transfusion-dependent beta thalassemia (TDT) didn’t fare well after a thorough review by the United […]

UK’s NICE Rejects bluebird bio Questions Value Price Tag & Nominal Clinical Evidence While Sponsor Shocked
3 weeks ago
Share

Gene-Therapy City: Philadelphia Biotech Ventured Continue Funding Wave with ‘Centyrins’ Developer Aro Biotherapeutics Secures $88m

A Philadelphia gene-therapy biotech venture just raised $88 million in investment from Johnson & Johnson and other investors, domestic and […]

Gene-Therapy City Philadelphia Biotech Ventured Continue Funding Wave with ‘Centyrins’ Developer Aro Biotherapeutics Secures $88m
2 months ago
Share

Jeito Capital leads €20 Million Investment in InnoSkel, a New Gene Therapy Company and Leader in Rare Skeletal Disorders

Jeito Capital (“Jeito”), a rapidly emerging independent investor dedicated to biotech and biopharma, today announces that it has led a […]

Jeito Capital leads €20 Million Investment in InnoSkel, a New Gene Therapy Company and Leader in Rare Skeletal Disorders
3 months ago
Share

CRISPR-based Gene Therapy Shows Initial Promise Targeting Sickle Cell Disease & Thalassemia

A painful inherited blood disorder affecting millions of people, especially Black people, occurs because of a deficiency of red blood […]

CRISPR-based Gene Therapy Shows Initial Promise Targeting Sickle Cell Disease & Thalassemia
3 months ago
Share

Axovant Gene Therapies Announces FDA Clearance of IND for AXO-AAV-GM2 Gene Therapy in Tay-Sachs and Sandhoff Diseases

Axovant Gene Therapies Ltd. (NASDAQ: AXGT), a clinical-stage company developing innovative gene therapies, today announced that the U.S. Food and […]

Axovant Gene Therapies Announces FDA Clearance of IND for AXO-AAV-GM2 Gene Therapy in Tay-Sachs and Sandhoff Diseases
4 months ago
Share

Bayer Acquires Gene Therapy Leader AskBio for up to $4 Billion Deal: Becoming a Global Gene Therapy Powerhouse

Germany-based Bayer acquired AskBio’s industry leading AAV-based gene therapy platform to accelerate its ability to bring urgently needed treatments to […]

Bayer Acquires Gene Therapy Leader AskBio for up to $4 Billion Deal Becoming a Global Gene Therapy Powerhouse
4 months ago
Share

Gene Therapy for Treatment of Limb-Girdle Muscular Dystrophy Type 2E Shows Sustained Promise 18 Months Post Admin

Sarepta Therapeutics, Inc. (NASDAQ: SRPT), positioning itself as a leader in precision genetic medicine for rare diseases, recently announced positive […]

Gene Therapy for Treatment of Limb-Girdle Muscular Dystrophy Type 2E Shows Sustained Promise 18 Months Post Admin
5 months ago
Share

Errant Gene Therapeutics (“EGT”) asks European Authorities to Re-examine the Approval Process of Zynteglo, While US Litigation Moves Forward

Picking up on the ongoing “Family Man” saga, in New York Court, EGT claims that Zynteglo, the Bluebird Bio product […]

Errant Gene Therapeutics (“EGT”) asks European Authorities to Re-examine the Approval Process of Zynteglo, While US Litigation Moves Forward
5 months ago
Share

Gene Therapy Startup Kriya Therapeutics Raised $80.5m in A Round & Now Announces Gene Therapy MFG Facility in RTP

Kriya Therapeutics announced today that it has secured a 51,350 square foot operational manufacturing facility in Research Triangle Park (RTP), North […]

Gene Therapy Startup Kriya Therapeutics Raised $80.5m in A Round & Now Announces Gene Therapy MFG Facility in RTP
7 months ago
Share

Posts navigation

Older posts

Latest Podcasts

Alan Cannell talks COVID-19: Nobody Likes Cheap Solutions | Podcast S2 E41

Dr. Pierre Kory Talks Covid-19, Ivermectin and the FLCCC | Podcast E43

An Interview With Patricia Carter: Patient Engagement and Retention in Clinical Trials

Dr. Negin Hajizadeh: Researchers Finding A Very Effective Treatment For Covid-19 In New Study

Dr. Jean-Jacques Rajter and Dr. Juliana Cepelowicz Rajter Discuss Ivermectin In Broward County | Podcast S2 E 27

159 W Broadway, Suite 200
Salt Lake City, UT 84101

[email protected]

Connect With Us

TRIALSITE NEWS IS THE ONLY DIGITAL MEDIA DEDICATED 100% TO TRANSPARENT AND OPEN COVERAGE OF CLINICAL RESEARCH TRIAL SITES AROUND THE GLOBE. BASED IN THE SILICON SLOPES IN DOWNTOWN SALT LAKE CITY, UTAH, WE ARE FOUNDED BY A TEAM OF EXPERTS IN THE CLINICAL TRIALS INDUSTRY AND DEDICATED TO TRANSPARENCY, QUALITY AND CLINICAL TRIAL INNOVATION.

© 2021 TRIALSITE NEWS. ALL RIGHTS RESERVED.